You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc. (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-07-08 17 Redacted Document pleadings of non-infringement of U.S. Patent 10,307,419 (“the ’419 patent”). Prinston’s proposed brexpiprazole… 461 patents, including the ’419 patent. (D.I. 1, Ex. G (the ’419 patent)). The ’419 patent issued … Notably, the ’419 patent expires years after the other patents asserted in this litigation,…only patent directed to specific formulations with specific obvious excipients. The other patents- in-suit…Literally Infringe the ’419 Patent Both independent claims of the ’419 patent cover, in pertinent part External link to document
2020-08-03 24 Redacted Document 109 patent”); 9,839,637 (“the ’637 patent”); and 10,307,419 (“the ’419 patent”). The ’419 patent relates…end this litigation. U.S. Patent No. 10,307,419 is just one of five patents asserted against Prinston.… United States Patent Nos. 7,888,362 (“the ’362 patent”); 8,349,840 (“the ’840 patent”); 8,618,109 (“…to the ’419 patent, original claim 1 recited HPC as a binder. Ex. 7 (Original U.S. Patent Application…NATURE AND STAGE OF THE PROCEEDINGS This patent infringement action arises from Prinston’s filing External link to document
2019-10-15 4 Patent/Trademark Report to Commissioner of Patents ,349,840 ;8,618,109 ;9,839,637 ;10,307,419. (lak) (Entered: 10/16/2019) 15 October 2019 PACER … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362 ;8,349,840… 15 October 2019 1:19-cv-01956 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Johnson and Johnson
Harvard Business School
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.